It took us eight years to learn how to sell a ghost.
That’s because what we do works behind the scenes.
Every time a patient sees a healthcare provider, our technology checks whether the next medically necessary service was delivered. If something was missed, we identify it—without disrupting workflows or changing how providers practice.
Most providers never know those services were overlooked. Our algorithms do.
Built into the systems providers already use—like electronic health records and healthcare data platforms—Precision helps ensure patients get the care they need, when they need it.
One healthcare technology leader put it simply:
Delivering healthcare without Precision is like using Google Maps without entering a destination.
Precision Healthcare Technologies should not be evaluated using traditional venture or private equity underwriting models.
We are a self-funded healthcare infrastructure platform that owns its technology outright and operates without a burn rate. Nearly nineteen years of technology development and eight years of model iteration were completed before reaching a scalable, repeatable operating model.
Capital and strategic partnerships are used to accelerate contracted deployment, expand distribution, and scale revenue-producing activity—not to fund speculative R&D, customer discovery, or prolonged operating losses.
Precision functions as connective infrastructure across healthcare rather than a point solution. The platform simultaneously enables compliance intelligence, AI-driven workflow orchestration, and consumer-controlled health records. These capabilities compound value rather than compete for it.
Traditional financial models often miss this category because it sits between venture capital and buyout structures. The risk profile is materially lower than early-stage healthcare investing because the technology is built, the model is proven, and revenue scales with execution rather than invention.
Precision represents an opportunity to deploy capital against infrastructure-level economics with asymmetric upside and controlled downside.
Copyright © 2026 PHT Finance - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.